SCHEMBL6844140

SCHEMBL6844140

COc1ccc(C(NCC=O)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.44
KIF11 P52732 6/20 0.44
KCNH2 Q12809 1/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
TK1 P04183 1/20 0.40
GAA P10253 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
TRPA1 O75762 1/20 0.40
LTA4H P09960 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11005672 0.84 PKM (0.48) KCNN4KIF11KCNH2RAB9ANPC1
SCHEMBL6669392 0.82 KCNN4 (0.48) KCNN4KIF11RAB9ANPC1SMN1; SMN2
SCHEMBL6854126 0.81 KIF11 (0.42) KCNN4KIF11KCNH2RAB9ANPC1
SCHEMBL6750468 0.81 KIF11 (0.42) KCNN4KIF11KCNH2RAB9ANPC1
SCHEMBL30610089 0.79 KIF11 (0.49) KCNN4KIF11KCNH2RAB9ANPC1
SCHEMBL14356107 0.79 KIF11 (0.49) KCNN4KIF11KCNH2RAB9ANPC1
SCHEMBL12762284 0.79 KCNN4 (0.48) KCNN4KIF11KCNH2RAB9ANPC1
SCHEMBL14356119 0.79 KIF11 (0.55) KCNN4KIF11KCNH2SMN1; SMN2HTT
SCHEMBL4363002 0.78 KIF11 (0.49) KCNN4KIF11KCNH2SMN1; SMN2HTT
SCHEMBL12225852 0.78 KIF11 (0.49) KCNN4KIF11KCNH2SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040019000-A1 Polyalkyleneamine-containing oligomers ISIS PHARMACEUTICALS, INC. 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019000-A1 Polyalkyleneamine-containing oligomers FUS, NSF, PICALM KCNN4 2440/4885KIF11 2034/4885KCNH2 2740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.